Overview
Background
I am the lead of the Effective and Efficient Healthcare program at the Centre for the Business and Economics of Health at The University of Queensland. I also lead Health Technology Assessment for the Centre, which involves evaluating submissions made to the Australian Government to reimburse new medicines and medical devices through the Pharmaceutical benefits Scheme (PBS) and the Medicare Benefits Schedule (MBS). My research is focused on the economic evaluation of health interventions to inform decision making and promote value-based health care. I have pioneered the application of Value of Information (Research) analysis to enhance the efficiency of clinical trials and maximise the return on investment from medical research.
I have extensive experience working with key stakeholders including consumers, clinicians, decision makers and researchers. I am chief investigator on over $45 million Category 1 grants from the NHMRC, MRFF and ARC. In addition, I lead several projects for the Department of Health and other peak organisations.
I chair the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)-Oncology GroupI, and I am the past chair of the Clinical Oncology Society of Australia's (COSA)-Epidemiology Group and the Australian Clinical Trials Alliance (ACTA)-Research Prioritisation Group. I am an Associate Editor for Value in Health, and an Editorial Board Member for Medical Decision Making and PharmacoEconomics-open journals.
Availability
- Professor Haitham Tuffaha is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Doctor of Philosophy, Griffith University
Research interests
-
Economic Evaluation of Healthcare Interventions
-
Health Technology Assessment
-
Value-Based Health Care
-
Cancer Economics
-
Medications use and safety
Research impacts
My research has significantly influenced health policy in Australia and internationally and was pivotal in the allocation of almost $1 billion in new drugs and medical technologies in Australia over the past ten years. My research program about evaluating new health technologies using Value of Information/implementation analyses led to a paradigm shift in the economic evaluation of new interventions and improved patient access to health innovations (e.g., genetic testing, targeted therapies). My research shifted the way clinical trials are prioritised and funded towards a value-based approach, which informed the development of the Australian Clinical Trials Alliance Research Prioritisation Framework.
I have published over 100 peer reviewed articles and technical reports for leading organisations, including 45 technical reports for the Australian Government on the economic evaluation of novel drugs, devices and services for a range of conditions including cancer, genetic testing, cardiovascular disease and liver disease.
Works
Search Professor Haitham Tuffaha’s works on UQ eSpace
2023
Conference Publication
HER2 in situ hybridization testing in breast cancer: applying algorithm-assisted assessment to reduce interobserver variability in difficult cases
Gough, Madeline, Liu, Cheng, Srinivasan, Bhuvana, Wilkinson, Lisa, Dunk, Louisa, Yang, Yuanhao, Tuffaha, Haitham, Kryza, Thomas, Hooper, John D., Lakhani, Sunil R. and Snell, Cameron Edward (2023). HER2 in situ hybridization testing in breast cancer: applying algorithm-assisted assessment to reduce interobserver variability in difficult cases. 2023 ASCO Annual Meeting, Chicago, IL United States, 2-6 June 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.16_suppl.e13561
2023
Journal Article
Results from a type two hybrid‐effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway
Delaforce, Alana, Farmer, Shannon, Duff, Jed, Munday, Judy, Miller, Kristin, Glover, Lynne, Corney, Chris, Ansell, Gareth, Gutta, Naadir, Tuffaha, Haitham, Hardy, Janet and Hurst, Cameron (2023). Results from a type two hybrid‐effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway. Transfusion, 63 (4), 724-736. doi: 10.1111/trf.17287
2023
Other Outputs
(April 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, PICO Confirmation. Commonwealth of Australia, Canberra, ACT
Hettiarachchi, R. and Tuffaha, H. (2023). (April 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, PICO Confirmation. Commonwealth of Australia, Canberra, ACT. Canberra, ACT, Australia: Commonwealth of Australia.
2023
Journal Article
A review of the cost-effectiveness of genetic testing for germline variants in familial cancer
Teppala, Srinivas, Hodgkinson, Brent, Hayes, Sandi, Scuffham, Paul and Tuffaha, Haitham (2023). A review of the cost-effectiveness of genetic testing for germline variants in familial cancer. Journal of Medical Economics, 26 (1), 19-33. doi: 10.1080/13696998.2022.2152233
2022
Journal Article
Approaches to prioritising research for clinical trial networks: a scoping review
Morton, Rachael L., Tuffaha, Haitham, Blaya-Novakova, Vendula, Spencer, Jenean, Hawley, Carmel M., Peyton, Phil, Higgins, Alisa, Marsh, Julie, Taylor, William J., Huckson, Sue, Sillett, Amy, Schneemann, Kieran, Balagurunanthan, Anitha, Cumpston, Miranda, Scuffham, Paul A., Glasziou, Paul and Simes, Robert J. (2022). Approaches to prioritising research for clinical trial networks: a scoping review. Trials, 23 (1) 1000, 1-21. doi: 10.1186/s13063-022-06928-z
2022
Conference Publication
How would the choice of the multi-attribute utility instrument affect the cost-effectiveness of cancer interventions? A comparison of the FACT-8D and the AQoL
Tuffaha, H., Arora, S., Denehy, L. and Edbrooke, L. (2022). How would the choice of the multi-attribute utility instrument affect the cost-effectiveness of cancer interventions? A comparison of the FACT-8D and the AQoL. ISPOR Europe 2022, Vienna, Austria, 6-9 November 2022. New York, NY United States: Elsevier. doi: 10.1016/j.jval.2022.09.2001
2022
Conference Publication
Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer
Wang, Yufan, McCarthy, Alexandra and Tuffaha, Haitham (2022). Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer. COSA's 49th Annual Scientific Meeting Equitable cancer care for all: Gender, identity, culture, geography, and disease should not matter, Online, 2–4 November 2022. Chichester, West Sussex United Kingdom: Wiley-Blackwell.
2022
Conference Publication
How would the choice of health-related quality of life measure affect the cost-effectiveness of oncology interventions?
Tuffaha, Haitham, Arora, Shiksha, Denehy, Linda and Edbrooke, Lara (2022). How would the choice of health-related quality of life measure affect the cost-effectiveness of oncology interventions?. COSA's 49th Annual Scientific Meeting Equitable cancer care for all: Gender, identity, culture, geography, and disease should not matter, Online, 2–4 November 2022. Chichester, West Sussex United Kingdom: Wiley-Blackwell.
2022
Conference Publication
Genetic testing in prostate cancer: a scoping literature review
Edmunds, Kim, Arora, Shiksha, Roberts, Matthew, Fairbairn, David, Scuffham, Paul, Smith, David, Chambers, Suzanne, Horvath, Lisa and Tuffaha, Haitham (2022). Genetic testing in prostate cancer: a scoping literature review. COSA's 49th Annual Scientific Meeting Equitable cancer care for all: Gender, identity, culture, geography, and disease should not matter, Online, 2–4 November 2022. Chichester, West Sussex United Kingdom: Wiley-Blackwell.
2022
Other Outputs
Validation of Strokenomics Budget Impact Model for Stryker stent-based mechanical thrombectomy for acute ischaemic stroke
Edmunds, Kim and Tuffaha, Haitham (2022). Validation of Strokenomics Budget Impact Model for Stryker stent-based mechanical thrombectomy for acute ischaemic stroke. Brisbane, QLD Australia: The University of Queensland.
2022
Other Outputs
Assessing the impact of clinical trials: a scoping literature review
Tuffaha, Haitham, Birch, Stephen and Oakley, Padraig (2022). Assessing the impact of clinical trials: a scoping literature review. Melbourne, VIC Australia: Australian Clinical Trials Alliance.
2022
Journal Article
Exercise in preventing falls for men with prostate cancer: a modelled cost-utility analysis
Edmunds, Kim, Scuffham, Paul, Newton, Robert U., Galvão, Daniel A. and Tuffaha, Haitham (2022). Exercise in preventing falls for men with prostate cancer: a modelled cost-utility analysis. Supportive Care in Cancer, 30 (6), 5037-5046. doi: 10.1007/s00520-022-06900-2
2022
Other Outputs
A pilot study to prospectively estimate the health and economic return on research investment
Tuffaha, Haitham and Birch, Stephen (2022). A pilot study to prospectively estimate the health and economic return on research investment. Melbourne, VIC Australia: Australian Clinical Trials Alliance.
2022
Journal Article
Methodological approaches to cost-effectiveness analysis in Saudi Arabia: what can we learn? a systematic review
Maraiki, Fatma, Bazarbashi, Shouki, Scuffham, Paul and Tuffaha, Haitham (2022). Methodological approaches to cost-effectiveness analysis in Saudi Arabia: what can we learn? a systematic review. MDM Policy and Practice, 7 (1) 23814683221086869, 1-11. doi: 10.1177/23814683221086869
2021
Journal Article
Public hesitancy to COVID‐19 vaccine and the role of pharmacists in addressing the problem and improving uptake
Wubishet, Befikadu L., Tesfaye, Wubshet H., Khan, Md Nuruzzaman, Thomas, Jackson, Tuffaha, Haitham, Comans, Tracy A., Scuffham, Paul and Erku, Daniel A. (2021). Public hesitancy to COVID‐19 vaccine and the role of pharmacists in addressing the problem and improving uptake. Journal of Pharmacy Practice and Research, 51 (6), 494-500. doi: 10.1002/jppr.1784
2021
Journal Article
How can early stage economic evaluation help guide research for future vaccines?
Newall, A.T., Beutels, P., Tuffaha, H.W., Hall, P.S. and Jit, M. (2021). How can early stage economic evaluation help guide research for future vaccines?. Vaccine, 40 (2), 175-177. doi: 10.1016/j.vaccine.2021.11.017
2021
Journal Article
Impact of a new cost-effectiveness threshold implementation on cancer formulary decisions in Jordan
Treish, Imad, Al Rabayah, Abeer, Jaddoua, Saad and Tuffaha, Haitham (2021). Impact of a new cost-effectiveness threshold implementation on cancer formulary decisions in Jordan. PharmacoEconomics - Open, 6 (2), 137-145. doi: 10.1007/s41669-021-00293-4
2021
Journal Article
Cost‐effectiveness analysis of home‐based rehabilitation compared to usual care for people with inoperable lung cancer
Edbrooke, Lara, Denehy, Linda, Patrick, Cameron and Tuffaha, Haitham (2021). Cost‐effectiveness analysis of home‐based rehabilitation compared to usual care for people with inoperable lung cancer. European Journal of Cancer Care, 30 (6) ecc.13501, 1-11. doi: 10.1111/ecc.13501
2021
Journal Article
Comparative effectiveness of different localization techniques for non-palpable breast cancer. A systematic review and network meta-analysis
Athanasiou, Christos, Mallidis, Evangelos and Tuffaha, Hussein (2021). Comparative effectiveness of different localization techniques for non-palpable breast cancer. A systematic review and network meta-analysis. European Journal of Surgical Oncology, 48 (1), 53-59. doi: 10.1016/j.ejso.2021.10.001
2021
Conference Publication
Cost-effectiveness analysis of home-based rehabilitation in inoperable lung cancer
Edbrooke, Lara, Denehy, Linda, Patrick, Cameron and Tuffaha, Haitham (2021). Cost-effectiveness analysis of home-based rehabilitation in inoperable lung cancer. European-Respiratory-Society (ERS) International Congress, Thessaloniki Greece, Sep 26-30, 2021. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2021.OA4227
Funding
Current funding
Supervision
Availability
- Professor Haitham Tuffaha is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Evaluation of Indonesian Chronic Diseases Management Program: Patients participation, adherence to the treatment and cost-effectiveness of the program
Principal Advisor
Other advisors: Associate Professor Adam La Caze, Dr Kim Edmunds
-
Doctor Philosophy
Evaluation of Indonesian Chronic Diseases Management Program: Patients participation, adherence to the treatment and cost-effectiveness of the program
Principal Advisor
Other advisors: Associate Professor Adam La Caze, Dr Kim Edmunds
-
Doctor Philosophy
Assessing the Value for Money of Integrating Exercise as Therapy after Gynaecological Cancer Treatment
Principal Advisor
Other advisors: Professor Sandie McCarthy
Completed supervision
-
2024
Doctor Philosophy
Assessing the Value for Money of Integrating Exercise as Therapy after Gynaecological Cancer Treatment
Principal Advisor
Other advisors: Professor Sandie McCarthy
Media
Enquiries
Contact Professor Haitham Tuffaha directly for media enquiries about:
- Cancer Economics
- Health Economics
- Health Services Research
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: